Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Thorax. 2024 Mar 15;79(4):291-292. doi: 10.1136/thorax-2023-221329.

Authors

Nayia Petousi¹, Ian D Pavord², Brian Daniel Kent³

Affiliations

¹ Nuffield Department of Medicine & NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK nayia.petousi@ndm.ox.ac.uk.
² Nuffield Department of Medicine & NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
³ Department of Respiratory Medicine, St James's Hospital, Dublin, Ireland.

PMID: 38373823
DOI: 10.1136/thorax-2023-221329

No abstract available

Keywords: Asthma; COPD epidemiology.

Publication types

Editorial

MeSH terms

Asthma*
Humans
Inflammation
Lung
Pulmonary Disease, Chronic Obstructive*